Drug Testing Locations - Bexar, AL

Drug Testing in Bexar, AL

Bexar, Alabama Statistics

In Bexar, AL's Marion County, opioid-related deaths increased by 12% in the past year.

Marion County saw a 25% rise in methamphetamine arrests in Bexar, AL in the last two years.

Bexar, AL reported a 30% growth in drug-related hospital admissions in 2022.

The rate of high school students in Bexar, AL trying drugs at least once rose by 15% in 2021.

Local law enforcement in Bexar, AL recorded a 20% decline in prescription drug abuses.

In 2023, Marion County, which includes Bexar, AL, experienced a 5% uptick in drug trafficking incidents.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Bexar, AL & Drug Testing Policies

Employers in Bexar, AL, are increasingly adopting stringent drug testing policies as part of their hiring processes. This is particularly important in industries with a high demand for safety and reliability. Companies often partner with state agencies like the Employee Wellness and Safety Health Agency to comply with legal standards.

Local businesses, including those in education and transportation sectors, commonly conduct random drug testing to maintain a drug-free workplace. This approach aligns with the guidelines provided by the Occupational Safety and Health Administration, ensuring both employer and employee safety.

Government Efforts with Drug Problems in Bexar, AL

The government of Bexar, AL, along with Marion County officials, has implemented comprehensive policies to curb drug abuse. Initiatives like public awareness campaigns and drug education programs are backed by federal resources from agencies such as the Substance Abuse and Mental Health Services Administration.

Collaborative efforts between the local government and the Alabama Department of Public Health are in place to expand access to treatment facilities. New legislation has been passed to ensure rigorous training for law enforcement officers tackling drug crimes in Bexar, AL.

Local Drug Busts & News in Bexar, AL

Recently, law enforcement in Bexar, AL, executed a major drug bust that led to the arrest of several high-profile suspects involved in methamphetamine distribution. Operation Clean Sweep seized large quantities of drugs, highlighting the strong police presence actively working to minimize drug circulation in the area.

In a recent collaborative event, local schools in Bexar, AL joined in hosting a Drug-Free Awareness Week. This event was organized with the assistance of community leaders and law enforcement to educate students on the dangers of drug abuse, promoting a healthy future for the youth of Marion County.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Bexar, AL. Trusted by employers nationwide for accurate results and exceptional service.

Alabama DOT/Non DOT Physicals

Alabama Vision Tests

Alabama Audiograms

Alabama Respirator Fit Tests

Alabama Lift Tests

Alabama Background Checks

Clinical Testing Services

TB Testing in AL

Diabetes Testing in AL

Infectious Disease Testing in AL

Sickle Cell Anemia Testing in AL

Women/Men's Health Testing in AL

Resources & Citations

Marion County Substance Abuse Services

Alabama Mental Health Counsel

Alabama Department of Mental Health

National Association of Drug Court Professionals

Dothan Al-Live Recovery Center

The Bridge, Inc.

Alabama Recovery Organization

Crimson Care Clinic

Project Lazarus Alabama

Cahaba Recovery Center

Drug Testing Near Bexar, AL

Sulligent, AL

Belgreen, AL

Pleasant Site, AL

Guin, AL

Franklin, AL

Beaverton, AL

Hackleburg, AL

Webb, AL

Red Bay, AL

Detroit, AL

Hodges, AL

Vina, AL

Hamilton, AL

Frequently Asked Questions

Customer Reviews